ARS Pharmaceuticals, Inc. (SPRY)
3.82
+0.01
(+0.26%)
USD |
NASDAQ |
Nov 13, 10:20
ARS Pharmaceuticals Net Income (Annual) : -171.30M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -171.30M |
| December 31, 2024 | 7.998M |
| December 31, 2023 | -54.36M |
| December 31, 2022 | -34.68M |
| Date | Value |
|---|---|
| December 31, 2021 | -20.24M |
| December 31, 2020 | -32.95M |
| December 31, 2019 | -23.97M |
| December 31, 2018 | -17.58M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Capricor Therapeutics, Inc. | -105.04M |
| Sionna Therapeutics, Inc. | -75.27M |
| Nektar Therapeutics | -164.08M |
| Ardelyx, Inc. | -61.60M |
| Kyntra Bio, Inc. | -58.20M |